Julio Caballero

5.5k total citations · 1 hit paper
172 papers, 4.4k citations indexed

About

Julio Caballero is a scholar working on Molecular Biology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Julio Caballero has authored 172 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Molecular Biology, 58 papers in Computational Theory and Mathematics and 45 papers in Organic Chemistry. Recurrent topics in Julio Caballero's work include Computational Drug Discovery Methods (58 papers), Protein Structure and Dynamics (28 papers) and Synthesis and biological activity (18 papers). Julio Caballero is often cited by papers focused on Computational Drug Discovery Methods (58 papers), Protein Structure and Dynamics (28 papers) and Synthesis and biological activity (18 papers). Julio Caballero collaborates with scholars based in Chile, Cuba and Spain. Julio Caballero's co-authors include Michael Fernández, David Ramírez, Jans Alzate‐Morales, Leyden Fernández, William Tiznado, Alain Tundidor‐Camba, Fernando D. González‐Nilo, Ariela Vergara‐Jaque, Eduardo Fuentes and José Ignacio Abreu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Bioinformatics and PLoS ONE.

In The Last Decade

Julio Caballero

169 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Is It Reliable to Take the Molecular Docking Top Scoring Position as the Best Solution without Considering Available Structural Data?

2018 394 citations David Ramírez, Julio Caballero Molecules profile →

Peers

Countries citing papers authored by Julio Caballero

Since Specialization

Citations

This map shows the geographic impact of Julio Caballero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julio Caballero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julio Caballero more than expected).

Fields of papers citing papers by Julio Caballero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julio Caballero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julio Caballero. The network helps show where Julio Caballero may publish in the future.

Co-authorship network of co-authors of Julio Caballero

This figure shows the co-authorship network connecting the top 25 collaborators of Julio Caballero. A scholar is included among the top collaborators of Julio Caballero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julio Caballero. Julio Caballero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Advanced modeling of salt-inducible kinase (SIK) inhibitors incorporating protein flexibility through molecular dynamics and cross-docking 2025 ·Scientific Reports ·(unknown), (unknown), (unknown), Julio Caballero	1
2	Modeling of noncovalent inhibitors of the papain-like protease (PLpro) from SARS-CoV-2 considering the protein flexibility by using molecular dynamics and cross-docking 2024 ·Frontiers in Molecular Biosciences ·(unknown), (unknown), (unknown), Julio Caballero	4
3	Rosmarinic acid turned α-syn oligomers into non-toxic species preserving microtubules in Raw 264.7 cells 2024 ·Bioorganic Chemistry ·(unknown), (unknown), Julio Caballero, Francisco Melo, Leonardo Caballero, Carlos Areche, Denis Fuentealba, (unknown), Alberto Cornejo	1
4	Computational study of the binding orientation and affinity of noncovalent inhibitors of the papain-like protease (PLpro) from SARS-CoV-1 considering the protein flexibility by using molecular dynamics and cross-docking 2023 ·Frontiers in Molecular Biosciences ·(unknown), (unknown), Julio Caballero	2
5	Bitopic Sigma 1 Receptor Modulators to Shed Light on Molecular Mechanisms Underpinning Ligand Binding and Receptor Oligomerization 2021 ·Journal of Medicinal Chemistry ·Giacomo Rossino, Marta Rui, Pasquale Linciano, Daniela Rossi, Massimo Boiocchi, Marco Peviani, (unknown), Daniela Curti, Dirk Schepmann, Bernhard Wünsch, (unknown), Ariela Vergara‐Jaque, Julio Caballero, Simona Collina	7
6	Discovery of Novel TASK-3 Channel Blockers Using a Pharmacophore-Based Virtual Screening 2019 ·International Journal of Molecular Sciences ·David Ramírez, (unknown), (unknown), (unknown), Leandro Zúñiga, Aytuğ K. Kiper, Susanne Rinné, Miguel Reyes‐Parada, Niels Decher, Wendy González, Julio Caballero	17
7	New Insights into the Opening of the Occluded Ligand-Binding Pocket of Sigma1 Receptor: Binding of a Novel Bivalent RC-33 Derivative 2019 ·Journal of Chemical Information and Modeling ·Giacomo Rossino, (unknown), Julio Caballero, Dirk Schepmann, Bernhard Wünsch, Marta Rui, Daniela Rossi, (unknown), Simona Collina, Ariela Vergara‐Jaque	11
8	Mycobacterium tuberculosis serine/threonine protein kinases: structural information for the design of their specific ATP-competitive inhibitors 2018 ·Journal of Computer-Aided Molecular Design ·Julio Caballero, (unknown), (unknown)	20
9	Study of the interactions between Edaglitazone and Ciglitazone with PPARγ and their antiplatelet profile 2017 ·Life Sciences ·(unknown), Cèsar Sepùlveda, Julio Caballero, Iván Palomo, Eduardo Fuentes	8
10	New insights into steric and electronic effects in a series of phosphine ligands from the perspective of local quantum similarity using the Fukui function 2015 ·Journal of Molecular Modeling ·(unknown), Julio Caballero	8
11	Study of the Affinity between the Protein Kinase PKA and Peptide Substrates Derived from Kemptide Using Molecular Dynamics Simulations and MM/GBSA 2014 ·PLoS ONE ·Karel Mena‐Ulecia, Ariela Vergara‐Jaque, Horacio Poblete, William Tiznado, Julio Caballero	16
12	Synthesis of coumarin derivatives as fluorescent probes for membrane and cell dynamics studies 2014 ·European Journal of Medicinal Chemistry ·Olimpo García‐Beltrán, Osvaldo Yáñez, Julio Caballero, Antonio Galdámez, Natalia Mena, Marco T. Núñez, Bruce K. Cassels	6
13	Protective mechanisms of adenosine 5′-monophosphate in platelet activation and thrombus formation 2013 ·Thrombosis and Haemostasis ·Eduardo Fuentes, Lina Badimón, Julio Caballero, Teresa Padró, Gemma Vilahur, Marcelo Alarcón, (unknown), Iván Palomo	53
14	A Novel Class of Selective Acetylcholinesterase Inhibitors: Synthesis and Evaluation of (E)-2-(Benzo[d]thiazol-2-yl)-3-heteroarylacrylonitriles 2012 ·Molecules ·Pedro De‐la‐Torre, (unknown), Julio Caballero, Jairo Quiroga, Jans Alzate‐Morales, Margarita Cabrera, Jorge Trilleras	36
15	Identification of a potent and selective σ1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells 2011 ·Bioorganic & Medicinal Chemistry ·Daniela Rossi, (unknown), Mariangela Urbano, Raffaella Gaggeri, Massimo Serra, Leyden Fernández, Michael Fernández, Julio Caballero, Simone Ronsisvalle, Orazio Prezzavento, Dirk Schepmann, (unknown), Marco Peviani, Daniela Curti, Ornella Azzolina, Simona Collina	43
16	3D-QSAR (CoMFA and CoMSIA) and pharmacophore (GALAHAD) studies on the differential inhibition of aldose reductase by flavonoid compounds 2010 ·Journal of Molecular Graphics and Modelling ·Julio Caballero	59
17	Quantitative Structure–Activity Relationship of Organosulphur Compounds as Soybean 15‐Lipoxygenase Inhibitors Using CoMFA and CoMSIA 2010 ·Chemical Biology & Drug Design ·Julio Caballero, Michael Fernández, (unknown)	8
18	QSAR analysis for heterocyclic antifungals 2007 ·Bioorganic & Medicinal Chemistry ·Pablo R. Duchowicz, (unknown), Eduardo A. Castro, Michael Fernández, Julio Caballero	39
19	Quantitative structure–activity relationship to predict differential inhibition of aldose reductase by flavonoid compounds 2005 ·Bioorganic & Medicinal Chemistry ·Michael Fernández, Julio Caballero, Aliuska Morales Helguera, Eduardo A. Castro, Maykel Pérez González	75
20	Effects of β‐cyclodextrin–dextran polymer on stability properties of trypsin 2003 ·Biotechnology and Bioengineering ·Michael Fernández, María L. Villalonga, Julio Caballero, Alex Fragoso, Rong Cao, Reynaldo Villalonga	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact